Cargando…

Plasma Cell-Free DNA as a Novel Biomarker for the Diagnosis and Monitoring of Atherosclerosis

Atherosclerosis (AS) is the leading cause of cardiovascular diseases (CVDs) with a high rate of mortality worldwide. Plasma cell-free DNA (cfDNA), mainly originating from apoptosis, necrosis, and active secretion, has been recognized as a promising biomarker for the diagnosis and prognosis of multip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qian, Benheng, Li, Kexin, Lou, Xiaoying, Guo, Ye, Wang, Yidong, Wu, Lianpin, Zhang, Donghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600586/ https://www.ncbi.nlm.nih.gov/pubmed/36291116 http://dx.doi.org/10.3390/cells11203248

Ejemplares similares

Ferroptosis Associates With Diagnosis and Prognosis by Promoting Antitumor Immune Response in Melanoma
por: Qian, Benheng, et al.
Publicado: (2022)

m6A modification promotes miR-133a repression during cardiac development and hypertrophy via IGF2BP2
por: Qian, Benheng, et al.
Publicado: (2021)

Pyroptosis correlates with tumor immunity and prognosis
por: Lou, Xiaoying, et al.
Publicado: (2022)

YTHDF1 Promotes Cyclin B1 Translation through m(6)A Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation
por: Lou, Xiaoying, et al.
Publicado: (2021)

Association of N(6)-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts
por: Wu, Lianpin, et al.
Publicado: (2019)

HNRNPA2B1 Affects the Prognosis of Esophageal Cancer by Regulating the miR-17-92 Cluster
por: Li, Kexin, et al.
Publicado: (2021)

HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer
por: Li, Yiling, et al.
Publicado: (2023)

Peripheral Blood Leukocyte N6-methyladenosine is a Noninvasive Biomarker for Non-small-cell Lung Carcinoma
por: Pei, Yuqing, et al.
Publicado: (2020)

DNA N(6)-methyladenine modification in hypertension
por: Guo, Ye, et al.
Publicado: (2020)

Changes of N6-methyladenosine modulators promote breast cancer progression
por: Wu, Lianpin, et al.
Publicado: (2019)

Plasma cell-free DNA integrity: a potential biomarker to monitor the response of breast cancer to neoadjuvant chemotherapy
por: Wang, Wei, et al.
Publicado: (2019)

Plasma Microbial Cell-Free DNA Sequencing Technology for the Diagnosis of Sepsis in the ICU
por: Wang, Lili, et al.
Publicado: (2021)

Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer
por: Zhou, Xiaoying, et al.
Publicado: (2015)

Novel immune cell infiltration-related biomarkers in atherosclerosis diagnosis
por: Dong, Ruoyu, et al.
Publicado: (2023)

Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
por: Huang, Ao, et al.
Publicado: (2016)

Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
por: Hong, Shubin, et al.
Publicado: (2023)

Plasma cell-free DNA promise monitoring and tissue injury assessment of COVID-19
por: Jin, Xin, et al.
Publicado: (2023)

Oxidative stress biomarker triggered multiplexed tool for auxiliary diagnosis of atherosclerosis
por: Ma, Yuan, et al.
Publicado: (2023)

FUN14 domain-containing 1 promotes breast cancer proliferation and migration by activating calcium-NFATC1-BMI1 axis
por: Wu, Lianpin, et al.
Publicado: (2019)

Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis
por: Yiğit, Buket, et al.
Publicado: (2018)

Identification of Novel Biomarkers for Early Diagnosis of Atherosclerosis Using High-Resolution Metabolomics
por: Sardar, Syed Wasim, et al.
Publicado: (2023)

Liquid biopsy by combining 5-hydroxymethylcytosine signatures of plasma cell-free DNA and protein biomarkers for diagnosis and prognosis of hepatocellular carcinoma
por: Cai, Z., et al.
Publicado: (2021)

DNA hydroxymethylation combined with carotid plaques as a novel biomarker for coronary atherosclerosis
por: Jiang, Dan, et al.
Publicado: (2019)

Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
por: Núñez, Estefanía, et al.
Publicado: (2022)

Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up
por: Boons, Gitta, et al.
Publicado: (2022)

Novel Biomarkers for Diagnosis and Monitoring of Immune Thrombocytopenia
por: Allegra, Alessandro, et al.
Publicado: (2023)

Cell-Free Methylated PTGER4 and SHOX2 Plasma DNA as a Biomarker for Therapy Monitoring and Prognosis in Advanced Stage NSCLC Patients
por: Fleischhacker, Michael, et al.
Publicado: (2023)

Plasma cell-free DNA: a potential biomarker for early prediction of severe dengue
por: Phuong, Nguyen Thi Ngoc, et al.
Publicado: (2019)

Evaluation of circulating cell free DNA in plasma as a biomarker of different thyroid diseases()
por: Caglar, Ozge, et al.
Publicado: (2019)

Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer
por: Carrasco, Raquel, et al.
Publicado: (2022)

A novel Alu-based real-time PCR method for the quantitative detection of plasma circulating cell-free DNA: Sensitivity and specificity for the diagnosis of myocardial infarction
por: LOU, XIAOLI, et al.
Publicado: (2015)

Discovery of plasma biomarkers for predicting the severity of coronary artery atherosclerosis by quantitative proteomics
por: Ku, Eu Jeong, et al.
Publicado: (2020)

Monitoring multiple myeloma in the peripheral blood based on cell-free DNA and circulating plasma cells
por: Mack, Elisabeth K. M., et al.
Publicado: (2022)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
por: Vanderstichele, Adriaan, et al.
Publicado: (2022)

Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring
por: Li, Shuo, et al.
Publicado: (2023)

Identification of lipid metabolism-related biomarkers for diagnosis and molecular classification of atherosclerosis
por: Pan, Xue, et al.
Publicado: (2023)

miR-1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
por: Pei, Yuqing, et al.
Publicado: (2020)

[Corrigendum] miR‑1299/NOTCH3/TUG1 feedback loop contributes to the malignant proliferation of ovarian cancer
por: Pei, Yuqing, et al.
Publicado: (2023)

Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
por: Qi, Ting, et al.
Publicado: (2023)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
por: Ye, Qian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h4iribkkggvect998ptbnleqho